Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Contemp Clin Trials. 2018 Feb 8;67:1–10. doi: 10.1016/j.cct.2018.02.002

Table 3.

Baseline characteristics of patients enrolled in the PROPEL trial.

Usual Care Group
Intervention Group
N Mean (SD) or % N Mean (SD) or %
Female (%) 280 79.8 398 88.1
African American (%) 208 59.0 332 73.2
Annual Family Income (%)
 < $10,000 70 19.9 86 19.0
 $10,000 – $19,999 73 20.8 95 21.0
 $20,000 – $39,999 79 22.5 112 24.8
 $40,000 – $59,999 48 13.7 69 15.3
 ≥ $60,000 71 20.2 83 18.4
 Missing 10 2.9 7 1.6
REALM-SF Score [0–7] 351 6.4 (1.1) 452 6.4 (1.2)
 ≤ 6 (≤ 8th grade) (%) 106 30.2 141 31.2
 7 (≥ 9th grade) (%) 245 69.8 311 68.8
Household Food Insecurity (0–5) 351 1.2 (1.7) 452 1.1 (1.6)
 Food Secure (%) 238 67.8 325 71.9
 Food Insecure (%) 113 32.2 127 28.1
Diabetes (%) 104 29.6 103 22.8
Age (y) 351 49.8 (13.6) 452 48.8 (12.7)
BMI (kg/m2) 351 37.2 (4.8) 452 37.3 (4.6)
Waist Circumference (cm) 349 113.9 (12.6) 451 113.1 (12.4)
Systolic Blood Pressure (mmHg) 350 122.6 (16.5) 452 123.1 (16.3)
Diastolic Blood Pressure (mmHg) 350 78.4 (10.6) 452 79.7 (10.6)
Glucose (mg/dL) 344 112.3 (39.9) 438 106.5 (31.9)
Total Cholesterol (mg/dL) 340 180.0 (36.7) 433 179.6 (37.5)
HDL-cholesterol (mg/dL) 343 47.7 (14.4) 437 50.4 (14.4)
Triglycerides (mg/dL) 333 131.6 (69.4) 410 125.3 (72.8)
LDL-cholesterol (mg/dL) 328 106.7 (31.5) 401 105.7 (32.9)